Tadalista CT 20 is an orodispersible tablet containing 20 mg of Tadalafil, used to treat erectile dysfunction (ED). Like all medications metabolized by the liver, it can have implications for liver function, particularly in certain individuals. Here’s a detailed explanation: 1. How Tadalafil Is Metabolized Tadalafil is primarily metabolized in the liver via the CYP3A4 enzyme system. Most healthy men with normal liver function can metabolize Tadalafil without problems. 2. Potential Effects on Liver Function Mild liver enzyme elevation: Some users may experience temporary increases in liver enzymes (ALT, AST), which usually normalize after stopping the medication. Risk in pre-existing liver disease: Men with severe liver impairment (like cirrhosis or hepatitis) may metabolize the drug more slowly, increasing the risk of higher blood levels, prolonged effects, and stronger side effects. Rare serious effects: Very rarely, PDE5 inhibitors like Tadalafil have been linked to hepatotoxicity (liver injury), but this is uncommon and often associated with other risk factors, medications, or alcohol use. 3. Precautions People with moderate to severe liver disease should use Tadalista CT 20 only under medical supervision, and the dose may need adjustment or avoidance. Regular liver function tests may be recommended for individuals on long-term therapy with pre-existing liver conditions. Avoid combining with other hepatotoxic drugs or excessive alcohol, which can strain the liver. For most men with normal liver function, Tadalista CT 20 is safe and unlikely to affect liver health. The main concern arises in men with existing liver disease, who may experience slower drug metabolism, higher blood levels, and potential liver stress. Always consult a healthcare provider before using Tadalafil if you have liver issues.